Table 2. Characteristics of Patients... | American Society of Hematology

Table 2.

Characteristics of Patients With Anaplastic Large-Cell Lymphoma According to the Phenotype of Tumor Cells

Characteristic	B	T	Null	P
No.^*	56	49	33
Sex
M	30	38	19
F	26	11	14	.03
Age (yr)
≤60	36	41	23
>60	20	8	10	.08
Performance status^†
0-1	41	36	21
>1	14	11	12	.4
B symptoms^†
Absent	28	24	13
Present	27	24	20	.5
Mediastinal involvement	26	12	13	.07
Extranodal sites
Bone marrow	7	7	6	.7
Liver	4	8	3	.3
Spleen	14	6	5	.2
Central nervous system	5	3	3	.8
Skin	3	13	5	.01
Lung	10	6	7	.5
Gut	3	3	3	.8
Bone	4	3	4	.6
Waldeyer's ring	5	2	4	.8
No. of extranodal sites
0-1 site	41	38	27
>1 sites	15	11	6	.6
Ann Arbor stage
I-II	20	27	10
III-IV	36	22	23	.05
LDH level^†
≤1 × normal	19	32	13
>1 × normal	31	16	18	.01
Albumin level^*
≤30 g/L	10	15	7
>30 g/L	43	33	25	.3
International prognostic index³¹^†
Low	16	31	12
Low-intermediate	16	4	6
High-intermediate	9	5	8
High	10	9	5	.01
Treatment received
ACVBP	28	20	17
m-BACOD	6	13	2
NCVBP	7	7	6
VIM3/ACVBP	8	6	3
CVP/CTVP	7	3	5	.3

Characteristic	B	T	Null	P
No.^*	56	49	33
Sex
M	30	38	19
F	26	11	14	.03
Age (yr)
≤60	36	41	23
>60	20	8	10	.08
Performance status^†
0-1	41	36	21
>1	14	11	12	.4
B symptoms^†
Absent	28	24	13
Present	27	24	20	.5
Mediastinal involvement	26	12	13	.07
Extranodal sites
Bone marrow	7	7	6	.7
Liver	4	8	3	.3
Spleen	14	6	5	.2
Central nervous system	5	3	3	.8
Skin	3	13	5	.01
Lung	10	6	7	.5
Gut	3	3	3	.8
Bone	4	3	4	.6
Waldeyer's ring	5	2	4	.8
No. of extranodal sites
0-1 site	41	38	27
>1 sites	15	11	6	.6
Ann Arbor stage
I-II	20	27	10
III-IV	36	22	23	.05
LDH level^†
≤1 × normal	19	32	13
>1 × normal	31	16	18	.01
Albumin level^*
≤30 g/L	10	15	7
>30 g/L	43	33	25	.3
International prognostic index³¹^†
Low	16	31	12
Low-intermediate	16	4	6
High-intermediate	9	5	8
High	10	9	5	.01
Treatment received
ACVBP	28	20	17
m-BACOD	6	13	2
NCVBP	7	7	6
VIM3/ACVBP	8	6	3
CVP/CTVP	7	3	5	.3

Four other patients had both B- and T-cell markers and four patients had histiocytic type.

Data were unavailable for some patients.